Chamber and committees

The Shingles vaccination programme was first introduced in Scotland in 2013. In 2023, the Joint Committee on Vaccination and Immunisation (JCVI) recommended the use of a new two-course vaccine and the expansion of the age cohorts to protect individuals at an earlier age. They recommended a phased implementation over ten years. Currently, individuals who are age 65 and 70, over age 50 with a severely weakened immune system and people with certain health conditions are eligible for two doses of shingles vaccine. The second dose is usually offered between 2 and 12 months after the first. Eligible individuals will be contacted by their local NHS Immunisation team. Most Immunisation teams begin inviting patients forward from January onwards.

In due course, those who reach age 60 or 65 years during the period 1 September 2028 to 31 August 2033 will become eligible from 1 September in the relevant year.

Recent research suggests vaccination for shingles with the live attenuated herpes zoster vaccine (Zostavax®) could be linked to a reduction in the risk of developing dementia.

In the UK, Zostavax®, a live vaccine, was routinely offered to those eligible for the NHS shingles programme and not contraindicated to the vaccine.

In February 2019, the Joint Committee on Vaccination and Immunisation recommended that Shingrix® a non-live vaccine, should replace Zostavax® in the routine programme and since 1 September 2023, all newly eligible individuals have been offered the non-live shingles vaccine Shingrix®.

The Scottish Government published its first national assessment of genetic introgression in wild salmon in 2021 using data collected under the National Electrofishing Programme for Scotland (NEPS) in 2018 and 2019, combined with targeted sampling in the vicinity of freshwater smolt rearing facilities: https://data.marine.gov.scot/dataset/national-assessment-influence-farmed-salmon-escapes-genetic-integrity-wild-scottish-atlantic

The research found evidence of introgression was concentrated in areas of marine aquaculture production on the west coast and areas with freshwater smolt rearing. Outside these areas, there was no strong evidence of introgression pressures. The results highlighted how important it is to reduce the risk of farmed fish escapes, to protect the integrity of wild salmon populations in areas of aquaculture production.

This was the first report of the National Introgression Programme for Scotland (NIPS) which is a nationwide project that is researching the link between fish farm escapes and introgression in wild salmon populations.

A larger number of sites were sampled in 2021 and 2023 as part of NEPS surveys (National Electrofishing Programme for Scotland). This should increase the spatial resolution of samples and confidence in the findings, while also allowing comparison across years. Analysis will be submitted shortly for peer review.

Following a large escape at one of its farms (Carradale) in 2020, Mowi funded a study to determine if introgression was occurring. No evidence of impact or introgression was found following the escape event. The report suggests that the effects of farm escapes can be complex depending on numbers of escapes, timing, status of wild stocks, and the maturation status of the escapees: https://www.gov.scot/publications/examination-levels-farm-wild-hybridisation-south-west-scotland-north-east-england-following-large-scale-farm-salmon-escape-event-2020/

We have had extensive engagement with stakeholders – including consumer organisations such as Consumer Scotland – to ensure we understand all perspectives in this debate and represent this in our engagement with the UK Government.

At launch we substantially widened eligibility for Funeral Support Payment in comparison to the UK Government’s funeral payment. We recognised the complex nature of family relationships and introduced flexibility, meaning that the applicant does not have to be the closest relative of the deceased.

We regularly consider how to improve our payments and last year introduced amendment regulations to make improvements to Funeral Support Payment, further supporting bereaved people and helping people who are struggling to pay for a funeral. The changes included extending the definition of funeral to include alkaline hydrolysis, providing assistance for funerals abroad in exceptional circumstances and removing the cap for funerals outwith the deceased’s local area.

The information requested is not held centrally by the Scottish Government and is a matter for individual public bodies. The Equalities and Human Rights Commission (EHRC) is the body responsible for regulating and enforcing the Equality Act 2010. The Scottish Government is already undertaking a review of existing policies, guidance and legislation impacted by the recent Supreme Court judgment but will require to fully consider the revised Guidance and Code from the EHRC when it is issued, along with the Supreme Court judgment itself, before any changes could be made.

In the current parliamentary session to date the Emerging Energy Technologies Fund has spent a total of £15.3 million on grant awards:

• £6.8m to 31 projects, via the Hydrogen Innovation Scheme (details at: Emerging Energy Technologies Fund - Hydrogen Innovation Scheme: successful projects - gov.scot)
• £3.1m to the Storegga Speyside Hydrogen Project (details at: Green hydrogen production - gov.scot)
• £3.4m to 11 projects, following the 2024/25 green hydrogen funding call (details at: £3.4 million for Scotland’s hydrogen future - gov.scot)
• £2.0m to National Gas Transmission Plc. to support the pre-Front End Engineering and Design phase of the SCO2T Connect Project.

Based on 2024 estimates, Crown Estate Scotland projects a revenue from ScotWind developments of £3.42m per gigwatt over the lifetime of the project. If leased through ScotWind then Inch Cape (1.08GW installed capacity) would return £3.7m annually.

The figures provided are estimates only – actual revenues achieved will be dependent on a range of issues, including those affecting deployment scale, and timing and windspeeds.

The Scottish Government is clear that all nurse agency workers should be accessed via the relevant national procurement framework operated by NHS National Services Scotland unless in exceptional circumstances. This approach supports efforts by NHS Scotland Boards to ensure that all engagements involving nurse agency workers represent value for money and contribute towards the delivery of high quality patient care.

With regards to the engagement of medical agency workers, our recently concluded Medical Locum Task and Finish Group considered the experience of NHS England in adopting price caps and concluded that such a step was unlikely to aid efforts to ensure best value in respect of such engagements. Instead, all NHS Scotland Boards are asked to operate robust governance processes in respect of decisions concerning the engagement of medical agency workers, ensuring that such workers are only used as a measure of last resort. Where this is the case, steps should be taken to ensure best value is secured in relation to such engagements, including through the development of clear exit strategies where possible.

There are existing protections for freedom of speech and the Equality Act 2010 protects people from discrimination or harassment at work or in other areas of their life, because of their religious or philosophical beliefs.

The Equality Act 2010 is mainly reserved to the UK Parliament and UK Government. The regulator, the Equality and Human Rights Commission, has issued guidance on avoiding discrimination and harassment in the workplace and there is a Statutory Code of Practice on Employment.

Freedom of speech is a qualified right and the ways in which a person’s religion or belief is manifested might not be protected if this impacts on the legal rights of others, including those with the protected characteristic of gender reassignment, not to be discriminated against or harassed.